Geodon approved for adjunctive maintenance treatment of bipolar I disorder - MPR
Links shared publicly online about this topic.
- 1,588total visits
Geodon approved for adjunctive maintenance treatment of bipolar I disorder - MPR
empr.com —
View full resource at empr.com
Tags: Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, FDA, Geodon, Zeldox, Eskalith, Pfizer
Most Recently Shared on November 20, 2009 at 10:14 pm By:
MPR News: Geodon approved for adjunctive maintenance treatment of bipolar I disorder: The FDA has approved Geodon (... http://bit.ly/7IlmwH
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net
pharmainfo.net — “ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net” View full resource at pharmainfo.net
Most Recently Shared on February 25, 2011 at 1:15 am By:
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of ... http://bit.ly/hQ3HCe #bipolar
Abilify approved as adjunct for maintenance treatment of bipolar disorder - ONA
oncologynurseadvisor.com — “Bristol-Myers Squibb and Otsuka announced that Abilify (aripiprazole) has been approved by the FDA as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 22, 2011 at 7:15 pm By:
Abilify approved as adjunct for maintenance treatment of bipolar disorder http://goo.gl/fb/6ZuIk
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate - Business Wire - Wire - BradentonHerald.com
bradenton.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. , announced today that the U.S. Food and Drug Administration (FDA) has approved ABILIFY ® (aripiprazole) as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of Bipolar I Disorder.” View full resource at bradenton.com
Most Recently Shared on February 17, 2011 at 5:02 pm By:
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I ... http://bit.ly/fnyJ5i #bipolar
Saphris gains indications - ONA
oncologynurseadvisor.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 7:47 pm By:
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCl) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
drugs.com — “Geodon (ziprasidone) is used for the Adjunctive Maintenance Treatment of Bipolar Disorder. Includes Geodon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 23, 2009 at 11:39 pm By:
FDA Approves Geodon Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults - http://bit.ly/5k3r6q
Medical News: Ziprasidone Okayed for Bipolar Disorder - in Psychiatry, Bipolar Disorder from MedPage Today
medpagetoday.com — “The FDA has approved another antipsychotic agent -- ziprasidone (Geodon) -- for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.” View full resource at medpagetoday.com
Most Recently Shared on November 23, 2009 at 4:40 pm By:
The FDA has cleared ziprasidone (Geodon) for adjunct maintenance treatment of bipolar I disorder. More: http://bit.ly/8glSps
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
medicalnewstoday.com — “Pfizer announced that the u.s. food and drug administration (fda) has approved geodon® (ziprasidone hci) capsules for maintenance treatment of bipolar i disorder as an adjunct to lithium or va” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2009 at 3:39 pm By:
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment .. http://bit.ly/07JCNcs
Advertisement

